[Perioperative Antiplatelet Therapy in Patients with Coronary Stents Undergoing Elective Non-Cardiac Surgery]

Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Jan;53(1):49-53. doi: 10.12182/20220160508.
[Article in Chinese]

Abstract
in English, Chinese

Among patients undergoing elective non-cardiac surgery (NCS), those with coronary stent implants are gradually becoming a patient group that cannot be easily overlooked. Previous history of heart disease, coronary stents and antiplatelet agents expose these patients to dual perioperative risks of thrombosis and bleeding. Formulating appropriate plans for perioperative antiplatelet therapy will help reduce the risks and ensure the safety of patients. We herein reviewed and analyzed various aspects of perioperative antiplatelet therapy for patients with coronary stent implants undergoing elective NCS, and discussed prospective research directions in the field.

植入冠脉支架患者正在逐渐成为接受择期非心脏手术（non-cardiac surgery, NCS）的患者中不可忽视的一个群体。既往心脏疾病、冠脉支架以及抗血小板药物使这类患者在围术期面临着血栓形成和出血的双重风险。制定适宜的围术期抗血小板治疗方案将有助于降低风险，保障患者安全。本文将围绕目前支架患者择期NCS围术期抗血小板治疗的各个环节总结分析现有治疗方案，并探讨该领域未来的研究方向。

Keywords: Antiplatelet therapy; Coronary stents; Non-cardiac surgery.

Publication types

  • Review

MeSH terms

  • Elective Surgical Procedures
  • Hemorrhage
  • Humans
  • Platelet Aggregation Inhibitors* / therapeutic use
  • Prospective Studies
  • Stents*

Substances

  • Platelet Aggregation Inhibitors